Llwytho...
Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome
OBJECTIVE: To evaluate whether headache exacerbation associated with IV dihydroergotamine (DHE) infusion predicts medium-term headache outcome in patients with chronic migraine. METHODS: This was a retrospective chart review study of the UCSF Headache Center's use of IV DHE for chronic migraine...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Neurology |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Lippincott Williams & Wilkins
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4793780/ https://ncbi.nlm.nih.gov/pubmed/26843569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002406 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|